Protagonist Therapeutics posts 4Q loss

NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $3.1 million in its fourth quarter.

On a per-share basis, the Newark, California-based company said it had a loss of 15 cents.

The biopharmaceutical company posted revenue of $11.3 million in the period.

For the year, the company reported that its loss narrowed to $37 million, or $2.09 per share. Revenue was reported as $20.1 million.

Protagonist Therapeutics shares have increased slightly since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $20.89, a climb of 55 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX